SIGA Technologies, Inc. Profile Avatar - Palmy Investing

SIGA Technologies, Inc.

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox dise…

Drug Manufacturers - Specialty & Generic
US, New York [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

SIGA Technologies, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

SIGA Technologies, Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of SIGA Technologies, Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of SIGA's Analysis
CIK: 1010086 CUSIP: 826917106 ISIN: US8269171067 LEI: - UEI: -
Secondary Listings
SIGA has no secondary listings inside our databases.